Centre Hospitalier Universitaire De Saint Etienne
Clinical trials sponsored by Centre Hospitalier Universitaire De Saint Etienne, explained in plain language.
-
Hip replacement patients may benefit from optimized blood loss drug
Disease control CompletedThis study looked at the best dose of a drug called tranexamic acid to reduce blood loss during hip replacement surgery. 170 adults having a hip replacement took part. The goal was to find the dose that works best to lower the drop in hemoglobin after surgery.
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Jun 17, 2026 00:45 UTC
-
Hemophilia patients may face hidden bone loss risk
Knowledge-focused CompletedThis study looked at whether people with hemophilia (a bleeding disorder) are more likely to have weak bones (osteoporosis) compared to healthy people. Researchers measured bone density in 448 men aged 20 to 60, including those with hemophilia and healthy volunteers. The goal was…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:52 UTC
-
Power nap on night shift may shield heart health
Knowledge-focused CompletedThis study looked at whether a 30-minute nap during night shifts can improve blood vessel function in healthcare workers. 80 nurses and care assistants who work 12-hour night shifts took part. Researchers measured blood vessel health before and after 12 weeks of napping on duty.
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:26 UTC